94-15673. Animal Drugs, Feeds, and Related Products; Febantel-Trichlorfon Paste and Tylosin  

  • [Federal Register Volume 59, Number 123 (Tuesday, June 28, 1994)]
    [Unknown Section]
    [Page ]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 94-15673]
    
    
    [Federal Register: June 28, 1994]
    
    
    -----------------------------------------------------------------------
    
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    21 CFR Parts 520 and 558
    
    
    Animal Drugs, Feeds, and Related Products; Febantel-Trichlorfon 
    Paste and Tylosin
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Final rule.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is amending the animal 
    drug regulations to remove those portions of the regulations that 
    reflect approval of two new animal drug applications (NADA's). One NADA 
    is held by Miles, Inc., and provides for use of febantel-trichlorfon 
    paste. The other NADA is held by Nutra-Blend Corp. and provides for 
    manufacture of a Type A medicated article and Type B medicated feeds 
    containing tylosin. In a notice published elsewhere in this issue of 
    the Federal Register, FDA is withdrawing approval of the NADA's.
    
    EFFECTIVE DATE: July 8, 1994.
    
    FOR FURTHER INFORMATION CONTACT: Mohammad I. Sharar, Center for 
    Veterinary Medicine (HFV-216), Food and Drug Administration, 7500 
    Standish Pl., Rockville, MD 20855, 301-594-0749.
    
    SUPPLEMENTARY INFORMATION: In a notice published elsewhere in this 
    issue of the Federal Register, FDA is withdrawing approval of NADA 131-
    412 for Combotel/Negabot-Plus (febantel-trichlorfon) Paste held by 
    Miles, Inc., Agriculture Division, Animal Health Products, P.O. Box 
    390, Shawnee Mission, KS 66201, and NADA 122-158 held by Nutra-Blend 
    Corp., P.O. Box 485, Neosho, MO 64850, for manufacture of Type B 
    medicated feeds containing 4, 5, 10, and 20 grams per pound (g/lb) of 
    tylosin and a Type A medicated article containing 40 g/lb of tylosin. 
    The sponsors requested withdrawal of approval of the NADA's. This 
    document removes 21 CFR 520.903c and amends 21 CFR 558.625(b)(71) to 
    reflect the withdrawal of approval of these NADA's.
    
    List of Subjects
    
    21 CFR Part 520
    
        Animal drugs.
    
    21 CFR Part 558
    
        Animal drugs, Animal feeds.
        Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
    authority delegated to the Commissioner of Food and Drugs and 
    redelegated to the Center for Veterinary Medicine, 21 CFR parts 520 and 
    558 are amended as follows:
    
    PART 520--ORAL DOSAGE FORM NEW ANIMAL DRUGS
    
        1. The authority citation for 21 CFR part 520 continues to read as 
    follows:
    
        Authority: Sec. 512 of the Federal Food, Drug, and Cosmetic Act 
    (21 U.S.C. 360b).
    
    
    Sec. 520.903c  [Removed]
    
        2. Section 520.903c Febantel-trichlorfon paste is removed.
    
    PART 558--NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS
    
        3. The authority citation for 21 CFR part 558 continues to read as 
    follows:
    
        Authority: Secs. 512, 701 of the Federal Food, Drug, and 
    Cosmetic Act (21 U.S.C. 360b, 371).
    
    
    Sec. 558.625  [Amended]
    
        4. Section 558.625 Tylosin is amended by removing and reserving 
    paragraph (b)(71).
    
        Dated: June 15, 1994.
     Richard H. Teske,
     Acting Director, Center for Veterinary Medicine
    [FR Doc. 94-15673 Filed 6-27-94; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
06/28/1994
Department:
Health and Human Services Department
Entry Type:
Uncategorized Document
Action:
Final rule.
Document Number:
94-15673
Dates:
July 8, 1994.
Pages:
0-0 (None pages)
Docket Numbers:
Federal Register: June 28, 1994
CFR: (2)
21 CFR 558.625
21 CFR 520.903c